MedTrace Logo

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

NCT06703840 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2025-08-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are:

* Does the drug LIB-01 improve erectile function in males with erectile dysfunction?
* What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction.

Participants will:

* Take the drug LIB-01 or a placebo every day for 3 days
* Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests

Conditions

Interventions

DRUG

LIB-01

LIB-01 oral suspension

DRUG

LIB-01 Placebo

LIB-01 Placebo oral suspension

Sponsors & Collaborators

  • Dicot AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-08
Primary Completion
2025-07-19
Completion
2025-08-19

Countries

  • Denmark
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06703840 on ClinicalTrials.gov